Literature DB >> 19214363

Validation of Spanish versions of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ): a multicenter validation randomized study.

Tola B Omotosho1, Anne Hardart, Rebecca G Rogers, Joseph I Schaffer, William H Kobak, Audrey A Romero.   

Abstract

INTRODUCTION AND HYPOTHESIS: The purpose of this study is to validate Spanish versions of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ).
METHODS: Spanish versions were developed using back translation and validation was performed by randomizing bilingual women to complete the Spanish or English versions of the questionnaires first. Weighted kappa statistics assessed agreement for individual questions; interclass correlation coefficients (ICC) compared primary and subscale scores. Cronbach's alpha assessed internal consistency of Spanish versions. To detect a 2.7 point difference in scores with 80% power and alpha of 0.05, 44 bilingual subjects were required.
RESULTS: Individual questions showed good to excellent agreement (kappa > 0.6) for all but eight questions on the PFIQ. ICCs of primary and subscale scores for both questionnaires showed excellent agreement. (All ICC > 0.79). All Cronbach's alpha values were excellent (>0.84) for the primary scales of both questionnaires.
CONCLUSIONS: Valid and reliable Spanish versions of the PFIQ and PFDI have been developed.

Entities:  

Mesh:

Year:  2009        PMID: 19214363      PMCID: PMC3638216          DOI: 10.1007/s00192-008-0792-7

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  7 in total

1.  Reliability of health-related quality-of-life measures 1 year after surgical procedures for pelvic floor disorders.

Authors:  Patricia A Wren; Nancy K Janz; Linda Brubaker; Mary Pat Fitzgerald; Anne M Weber; Frankie B LaPorte; John T Wei
Journal:  Am J Obstet Gynecol       Date:  2005-03       Impact factor: 8.661

2.  Responsiveness of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ) in women undergoing vaginal surgery and pessary treatment for pelvic organ prolapse.

Authors:  Matthew D Barber; Mark D Walters; Geoffrey W Cundiff
Journal:  Am J Obstet Gynecol       Date:  2006-05       Impact factor: 8.661

Review 3.  Questionnaires for women with pelvic floor disorders.

Authors:  Matthew D Barber
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-11-21

4.  Spanish language translation of pelvic floor disorders instruments.

Authors:  Amy E Young; Paul M Fine; Rebecca McCrery; Patricia A Wren; Holly E Richter; Linda Brubaker; Morton B Brown; Anne M Weber
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-06-19

5.  Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders.

Authors:  M D Barber; M N Kuchibhatla; C F Pieper; R C Bump
Journal:  Am J Obstet Gynecol       Date:  2001-12       Impact factor: 8.661

6.  Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7).

Authors:  M D Barber; M D Walters; R C Bump
Journal:  Am J Obstet Gynecol       Date:  2005-07       Impact factor: 8.661

7.  Validation of a Spanish version of the Pelvic Organ Prolapse Incontinence Sexual Questionnaire.

Authors:  Audrey A Romero; Anne Hardart; William Kobak; Clifford Qualls; Rebecca Rogers
Journal:  Obstet Gynecol       Date:  2003-11       Impact factor: 7.661

  7 in total
  8 in total

1.  Reliability and validity of the Japanese version of the pelvic floor distress inventory-short form 20.

Authors:  Mikako Yoshida; Ryoko Murayama; Erika Ota; Maki Nakata; Shiro Kozuma; Yukio Homma
Journal:  Int Urogynecol J       Date:  2012-10-19       Impact factor: 2.894

2.  Chinese validation of Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire.

Authors:  Symphorosa Shing Chee Chan; Rachel Yau Kar Cheung; Alice Ka Wah Yiu; Jimmy Chak Man Li; Beatrice Pui Yee Lai; Kwong Wai Choy; Tony Kwok Hung Chung
Journal:  Int Urogynecol J       Date:  2011-05-25       Impact factor: 2.894

3.  Spanish translation and validation of four short pelvic floor disorders questionnaires.

Authors:  Alejandro D Treszezamsky; Deborah Karp; Madeline Dick-Biascoechea; Nazanin Ehsani; Christina Dancz; T Ignacio Montoya; Cedric K Olivera; Aimee L Smith; Rosa Cardenas; Tola Fashokun; Catherine S Bradley
Journal:  Int Urogynecol J       Date:  2012-09-14       Impact factor: 2.894

4.  Communication between physicians and Spanish-speaking Latin American women with pelvic floor disorders: a cycle of misunderstanding?

Authors:  Claudia Sevilla; Cecilia K Wieslander; Alexandriah N Alas; Gena C Dunivan; Aqsa A Khan; Sally L Maliski; Rebecca G Rogers; Jennifer Tash Anger
Journal:  Female Pelvic Med Reconstr Surg       Date:  2013 Mar-Apr       Impact factor: 2.091

5.  Colorectal and anal symptoms in women with urinary incontinence and pelvic organ prolapse.

Authors:  Khanh Ha; Christina Dancz; Rebecca Nelken; Mayra Contreras; Begüm Ozel
Journal:  Int Urogynecol J       Date:  2009-10-08       Impact factor: 2.894

6.  The relationship between uterine leiomyomata and pelvic floor symptoms.

Authors:  Christina E Dancz; Priyanka Kadam; Carrie Li; Kristen Nagata; Begüm Özel
Journal:  Int Urogynecol J       Date:  2013-08-07       Impact factor: 2.894

Review 7.  Questionnaires to evaluate pelvic floor dysfunction in the postpartum period: a systematic review.

Authors:  Lea Tami Suzuki Zuchelo; Italla Maria Pinheiro Bezerra; Adna Thaysa Marcial Da Silva; Jéssica Menezes Gomes; José Maria Soares Júnior; Edmund Chada Baracat; Luiz Carlos de Abreu; Isabel Cristina Esposito Sorpreso
Journal:  Int J Womens Health       Date:  2018-08-08

8.  Validation of a Spanish Version of the Prolapse and Incontinence Knowledge Questionnaire.

Authors:  Keila S Muñiz; Koraima Cedeño; Kathryn A Carson; Prerna R Pandya; Jacqueline Kikuchi; Danielle Patterson; Joan Blomquist; Stephanie Jacobs; Grace Chen Chi Chiung
Journal:  Female Pelvic Med Reconstr Surg       Date:  2021-11-01       Impact factor: 2.091

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.